Forte Biosciences, Inc. (FBRX)
NASDAQ · Healthcare
Forte Biosciences, Inc. Long Term Debt 2016–2019
Forte Biosciences, Inc. annual/quarterly long term debt history from 2016 to 2018. Long term debt refers to financial obligations that are due more than one year in the future.
- Forte Biosciences, Inc. long term debt for the quarter ending December 31, 2018 were 26.2M, a 622.79% increase year-over-year.
- Forte Biosciences, Inc. long term debt for 2018 were 26.2M, a 622.79% increase from 2017.
- Forte Biosciences, Inc. long term debt for 2017 were 3.6M, a 64.60% decrease from 2016.
- Forte Biosciences, Inc. long term debt for 2016 were 10.2M.
Long Term Debt
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Forte Biosciences, Inc. Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2018 | $26 |
| 2017 | $4 |
| 2016 | $10 |
| Forte Biosciences, Inc. Quarterly Long Term Debt (Millions of US $) | |
|---|---|
| 2018-12-31 | $26 |
| 2017-12-31 | $4 |
| 2016-12-31 | $10 |
Forte Biosciences, Inc. Long Term Debt — FAQ
Forte Biosciences, Inc. (FBRX) long term debt over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see FBRX's long term debt history?
The chart and table above show Forte Biosciences, Inc.'s long term debt by year and by quarter, including the growth rate.